Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.470
+0.010 (0.68%)
At close: Oct 8, 2025, 4:00 PM EDT
1.510
+0.040 (2.72%)
After-hours: Oct 8, 2025, 7:08 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $3.44 million as of October 8, 2025. Its market cap has increased by 147.81% in one year.
Market Cap
3.44M
Enterprise Value
-1.74M
1-Year Change
147.81%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $3.44M, a decrease of -96.20%. That is a compound annual growth rate of -48.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 3.42M | -11.34% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
| Nov 17, 2020 | 90.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |